ArticleOncoimmunology2020

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Maria-Filothei Lazaridou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.